SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001485003-22-000050
Filing Date
2022-04-28
Accepted
2022-04-28 08:13:05
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a.htm DEFA14A 16934
2 GRAPHIC keyquestionsforstockhold001.jpg GRAPHIC 231637
3 GRAPHIC keyquestionsforstockhold002.jpg GRAPHIC 222576
  Complete submission text file 0001485003-22-000050.txt   643805
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36296 | Film No.: 22862350
SIC: 2834 Pharmaceutical Preparations